InChI=1S/C34H58N2O25/c1- 8- 17(43) 22(48) 24(50) 32(53- 8) 61- 29- 28(19(45) 12(5- 38) 56- 34(29) 59- 26- 13(6- 39) 54- 30(52) 15(20(26) 46) 35- 9(2) 41) 60- 31- 16(36- 10(3) 42) 21(47) 27(14(7- 40) 57- 31) 58- 33- 25(51) 23(49) 18(44) 11(4- 37) 55- 33/h8,11- 34,37- 40,43- 52H,4- 7H2,1- 3H3,(H,35,41) (H,36,42) /t8- ,11+,12+,13+,14+,15+,16+,17+,18- ,19- ,20+,21+,22+,23- ,24- ,25+,26+,27- ,28- ,29+,30+,31+,32- ,33- ,34- /m0/s1 |
GABPUYHGBUJHRN-JXQLCXQFSA-N |
C[C@@H] 1O[C@@H] (O[C@H] 2[C@@H] (O[C@H] (CO) [C@H] (O) [C@@H] 2O[C@H] 2O[C@H] (CO) [C@H] (O[C@@H] 3O[C@H] (CO) [C@H] (O) [C@H] (O) [C@H] 3O) [C@H] (O) [C@H] 2NC(C) =O) O[C@H] 2[C@H] (O) [C@@H] (NC(C) =O) [C@H] (O) O[C@@H] 2CO) [C@@H] (O) [C@H] (O) [C@@H] 1O |
|
epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
|
|
View more via ChEBI Ontology
Outgoing
|
β- D- Galp- (1→4)- α- D- GalpNAc- (1→3)- [α- L- Fucp- (1→2)]- β- D- Galp- (1→4)- β- D- GlcpNAc
(CHEBI:70841)
has role
epitope
(CHEBI:53000)
β- D- Galp- (1→4)- α- D- GalpNAc- (1→3)- [α- L- Fucp- (1→2)]- β- D- Galp- (1→4)- β- D- GlcpNAc
(CHEBI:70841)
is a
amino pentasaccharide
(CHEBI:59268)
β- D- Galp- (1→4)- α- D- GalpNAc- (1→3)- [α- L- Fucp- (1→2)]- β- D- Galp- (1→4)- β- D- GlcpNAc
(CHEBI:70841)
is a
glucosamine oligosaccharide
(CHEBI:22485)
|
|
α- L- fucopyranosyl- (1→2)- [β- D- galactopyranosyl- (1→4)- 2- acetamido- 2- deoxy- α- D- galactopyranosyl- (1→3)]- β- D- galactopyranosyl- (1→4)- 2- acetamido- 2- deoxy- β- D- glucopyranose
|
6- deoxy- α- L- galactopyranosyl- (1→2)- [β- D- galactopyranosyl- (1→4)- 2- acetamido- 2- deoxy- α- D- galactopyranosyl- (1→3)]- β- D- galactopyranosyl- (1→4)- 2- acetamido- 2- deoxy- β- D- glucopyranose
|
IUPAC
|
α- L- Fuc- (1→2)- [β- D- Gal- (1→4)- α- D- GalNAc- (1→3)]- β- D- Gal- (1→4)- β- D- GlcNAc
|
ChEBI
|
α- L- fucosyl- (1→2)- [β- D- galactosyl- (1→4)- N- acetyl- α- D- galactosaminyl- (1→3)]- β- D- galactosyl- (1→4)- N- acetyl- β- D- glucosamine
|
ChEBI
|
α- L- Fucp- (1→2)- [β- D- Galp- (1→4)- α- D- GalpNAc- (1→3)]- β- D- Galp- (1→4)- β- D- GlcpNAc
|
JCBN
|
β- D- Gal- (1→4)- α- D- GalNAc- (1→3)- [α- L- Fuc- (1→2)]- β- D- Gal- (1→4)- β- D- GlcNAc
|
ChEBI
|
β- D- glucopyranose, O- 6- deoxy- α- L- galactopyranosyl- (1→2)- O- [O- β- D- galactopyranosyl- (1→4)- 2- (acetylamino)- 2- deoxy- α- D- galactopyranosyl- (1→3)]- O- β- D- galactopyranosyl- (1→4)- 2- (acetylamino)- 2- deoxy-
|
ChEBI
|
Galb1-4GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb
|
ChEBI
|
Galβ1-4GalNAcα1-3(Fucα1-2)Galβ1-4GlcNAcβ
|
ChEBI
|
WURCS=2.0/4,5,4/[a2122h- 1b_1- 5_2*NCC/3=O][a2112h- 1b_1- 5][a1221m- 1a_1- 5][a2112h- 1a_1- 5_2*NCC/3=O]/1- 2- 3- 4- 2/a4- b1_b2- c1_b3- d1_d4- e1
|
GlyTouCan
|
19443021
|
PubMed citation
|
Europe PMC
|
25568069
|
PubMed citation
|
Europe PMC
|
31537530
|
PubMed citation
|
Europe PMC
|
|